1upHealth spinoff GenHealth AI grabs $13M to fuel large medical model
Summary
GenHealth AI brought in $13 million in early funding last week that will help the company continue its work in what it is calling a large medical model, or LMM.The Boston-based company states that its LMM follows similar principles of a large language model (LLM), but instead of the transformer neural network being trained on text, GenHealth AIs LMM is trained on medical event data. The tool will be used for Medicare Advantage and Medicaid plans and Accountable Care Organizations.GenHealth AI said in a press release that it expects to add pilots of its model to pharmaceutical and life sciences organizations to accelerate workflows for synthetic data and clinical trial simulations.The main goal of LMM is to help the healthcare industry automate decisions based on individual patient histories, rather than rely on rules-based solutions that prevail today, Sahu wrote in a blog post on the GenHealth AI website. We are already seeing numerous companies in the industry take advantage of all the codified data to predict and manage patient futures via our LMM.According to the company, its generative AI models maintain an advantage over well-known LLMs due to its superior ability to assess patient care, workflow, financial claims and operational task datasets that follow common standards including HL7, FHIR, EDI and 837s.Generative AI has been the tech buzzword of the year following the release of the LLM ChatGPT-4 in March. Despite widespread excitement and promise in the new tools ability to change the face of technology, snags have already been revealed, drawing concern regarding the usage of LLMs in medicine.An LLM hallucination is similar to the phenomenon in humanssomething is made up. However, the company is currently testing the tool only on non-clinical decision tasks such as prior authorization.Various private and public organizations are stepping up to the plate to address ethical and safety issues regarding the tech.